Piscataway, NJ – May 22,2013 – Team EpiCeram is proud to announce its support of the National Eczema Association’s “Itching for a Cure” walk in New Jersey on June 8, 2013. Working together with the National Eczema Association, Team EpiCeram hopes to build awareness of eczema and help raise funds for a cure.
More than 30 million Americans suffer from eczema (or atopic dermatitis), an incurable disease of the skin, which is characterized by chronic itch and inflammation.
Click here to download full Press Release
Team EpiCeram, is walking to find a cure for eczema. “We’re excited to be joining the National Eczema Association to help millions of Americans who suffer from eczema”, said Elise Klein, Vice President, Brand Marketing and Strategic Planning. “Through this sponsorship and our participation we champion our commitment to help improve the lives of those living with eczema”.
EpiCeram Controlled Skin Barrier Emulsion is a prescription product that helps to relieve the burning and itching associated with skin conditions such as atopic dermatitis/eczema. It is the only topical agent that is formulated with three essential lipids (ceramides, free fatty acids, and cholesterol) in a physiologically balanced ratio, which mimics the lipid concentration found in the skin.
For more information and full prescribing information, please visit: www.epiceram-us.com.
EpiCeram Controlled Release Emulsion is distributed by PuraCap Pharmaceutical LLC.
About PuraCap Pharmaceutical LLC
PuraCap Pharmaceutical LLC is an emerging, fully integrated pharmaceutical company with expertise in product development, manufacturing, and bringing affordable, world-class quality products to their customers. The PuraCap corporate structure supports a two-pronged approach for global growth with dedicated companies in the areas of prescription brands (PuraCap Pharmaceutical) as well as prescription generics and OTC and private label brands. PuraCap Pharmaceutical continues to innovate using our soft gel expertise and developing other soft gel options. Go to www.puracap.com for more information.
All of the statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, are forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown. Some examples of known risks are: the impact of general economic conditions, general conditions in the pharmaceutical industry, changes in the regulatory environment in the jurisdictions in which PuraCap Pharmaceutical LLC does business, fluctuations in costs, and changes to the competitive environment due to consolidation or otherwise. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements.